Literature DB >> 18373954

Molecular genetics and racial disparities of uterine leiomyomas.

Essam-Eldin R Othman1, Ayman Al-Hendy.   

Abstract

Uterine leiomyomas (ULMs) are benign oestrogen-dependent tumours of the myometrium. They are the most common tumours of the female genital tract, affecting around 77% of the female population. ULMs are more common in Black women than White women. These tumours tend to develop earlier and be more numerous, larger in size and more symptomatic in Black women than other ethnic groups. The molecular mechanism underlying this ethnic disparity is not fully understood. Polymorphism of genes involved in oestrogen synthesis and/or metabolism (COMT, CYP17), variation in the expression levels or function of oestrogen and progesterone receptors or retinoic acid nuclear receptors (retinoid acid receptor-alpha, retinoid X receptor-alpha), or aberrant expression of micro-RNAs are some of the molecular mechanisms that may be involved.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18373954      PMCID: PMC4171730          DOI: 10.1016/j.bpobgyn.2008.01.014

Source DB:  PubMed          Journal:  Best Pract Res Clin Obstet Gynaecol        ISSN: 1521-6934            Impact factor:   5.237


  46 in total

1.  Gene expression profile of leiomyoma and myometrium and the effect of gonadotropin releasing hormone analogue therapy.

Authors:  Nasser Chegini; Juan Verala; Xiaoping Luo; Jingxia Xu; R Stan Williams
Journal:  J Soc Gynecol Investig       Date:  2003-04

2.  The role of microRNA genes in papillary thyroid carcinoma.

Authors:  Huiling He; Krystian Jazdzewski; Wei Li; Sandya Liyanarachchi; Rebecca Nagy; Stefano Volinia; George A Calin; Chang-Gong Liu; Kaarle Franssila; Saul Suster; Richard T Kloos; Carlo M Croce; Albert de la Chapelle
Journal:  Proc Natl Acad Sci U S A       Date:  2005-12-19       Impact factor: 11.205

Review 3.  Ethnic variation in risk for osteoporosis among women: a review of biological and behavioral factors.

Authors:  Pooja Pothiwala; Ellen M Evans; Karen M Chapman-Novakofski
Journal:  J Womens Health (Larchmt)       Date:  2006 Jul-Aug       Impact factor: 2.681

Review 4.  Pre-operative GnRH analogue therapy before hysterectomy or myomectomy for uterine fibroids.

Authors:  A Lethaby; B Vollenhoven; M Sowter
Journal:  Cochrane Database Syst Rev       Date:  2001

5.  An association between the allele coding for a low activity variant of catechol-O-methyltransferase and the risk for breast cancer.

Authors:  J A Lavigne; K J Helzlsouer; H Y Huang; P T Strickland; D A Bell; O Selmin; M A Watson; S Hoffman; G W Comstock; J D Yager
Journal:  Cancer Res       Date:  1997-12-15       Impact factor: 12.701

6.  Racial disparities in the surgical management of stress incontinence among female Medicare beneficiaries.

Authors:  Jennifer T Anger; Larissa V Rodríguez; Qin Wang; Er Chen; Chris L Pashos; Mark S Litwin
Journal:  J Urol       Date:  2007-05       Impact factor: 7.450

7.  Endometrial cancer: socioeconomic status and racial/ethnic differences in stage at diagnosis, treatment, and survival.

Authors:  Terri Madison; David Schottenfeld; Sherman A James; Ann G Schwartz; Stephen B Gruber
Journal:  Am J Public Health       Date:  2004-12       Impact factor: 9.308

8.  Pregnancy after uterine artery embolization for leiomyomata: the Ontario multicenter trial.

Authors:  Gaylene Pron; Eva Mocarski; John Bennett; George Vilos; Andrew Common; Leslie Vanderburgh
Journal:  Obstet Gynecol       Date:  2005-01       Impact factor: 7.661

9.  The effect of endogenous estradiol metabolites on the proliferation of human breast cancer cells.

Authors:  C Lippert; H Seeger; A O Mueck
Journal:  Life Sci       Date:  2003-01-10       Impact factor: 5.037

10.  Polycystic ovaries and premature male pattern baldness are associated with one allele of the steroid metabolism gene CYP17.

Authors:  A H Carey; D Waterworth; K Patel; D White; J Little; P Novelli; S Franks; R Williamson
Journal:  Hum Mol Genet       Date:  1994-10       Impact factor: 6.150

View more
  34 in total

1.  Forward Look: Tenth Anniversary of the Human Genome Sequence and 21 Century Postgenomics Global Health - A Close Up on Africa and Women's Health.

Authors:  Sanaa M Kamal; Louise Warnich; Lynnette R Ferguson; Sanjeeva Srivastava; Sandipan Ray; Denise Avard; Yann Joly; Michael Le Huynh; Madeline Page; Mario Masellis; Edward S Dove; David Gurwitz; Vural Ozdemir
Journal:  Curr Pharmacogenomics Person Med       Date:  2011-09-01

2.  The associations between the polymorphisms of the ER-α gene and the risk of uterine leiomyoma (ULM).

Authors:  Yi Feng; Xiaojuan Lin; Shengtao Zhou; Ning Xu; Tao Yi; Xia Zhao
Journal:  Tumour Biol       Date:  2013-06-09

Review 3.  Medical treatment of uterine leiomyoma.

Authors:  Mohamed Sabry; Ayman Al-Hendy
Journal:  Reprod Sci       Date:  2012-02-28       Impact factor: 3.060

4.  Can vitamin D reduce the risk of uterine fibroids?

Authors:  Ayman Al-Hendy; Marwa Badr
Journal:  Womens Health (Lond)       Date:  2014-07

Review 5.  Racial and ethnic disparities in benign gynecologic conditions and associated surgeries.

Authors:  Vanessa L Jacoby; Victor Y Fujimoto; Linda C Giudice; Miriam Kuppermann; A Eugene Washington
Journal:  Am J Obstet Gynecol       Date:  2010-04-28       Impact factor: 8.661

6.  Matrix production and remodeling as therapeutic targets for uterine leiomyoma.

Authors:  Caitlin Fujisawa; John J Castellot
Journal:  J Cell Commun Signal       Date:  2014-07-11       Impact factor: 5.782

7.  Efficacy and tolerability of CDB-2914 treatment for symptomatic uterine fibroids: a randomized, double-blind, placebo-controlled, phase IIb study.

Authors:  Lynnette K Nieman; Wendy Blocker; Tonja Nansel; Sheila Mahoney; James Reynolds; Diana Blithe; Robert Wesley; Alicia Armstrong
Journal:  Fertil Steril       Date:  2010-11-05       Impact factor: 7.329

8.  Expanding upon the Human Myometrial Stem Cell Hypothesis and the Role of Race, Hormones, Age, and Parity in a Profibroid Environment.

Authors:  Lauren E Prusinski Fernung; Kimya Jones; Aymara Mas; Daniel Kleven; Jennifer L Waller; Ayman Al-Hendy
Journal:  Am J Pathol       Date:  2018-08-01       Impact factor: 4.307

9.  Green tea extract inhibits proliferation of uterine leiomyoma cells in vitro and in nude mice.

Authors:  Dong Zhang; Mohamed Al-Hendy; Gloria Richard-Davis; Valerie Montgomery-Rice; Chakradhari Sharan; Veera Rajaratnam; Anjali Khurana; Ayman Al-Hendy
Journal:  Am J Obstet Gynecol       Date:  2010-01-13       Impact factor: 8.661

10.  Nanomedicine for uterine leiomyoma therapy.

Authors:  Hazem Ali; Gokhan Kilic; Kathleen Vincent; Massoud Motamedi; Erik Rytting
Journal:  Ther Deliv       Date:  2013-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.